Deerfield Mgmt HIF, L.P.
SEC CIK 1665736 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LRMR | Larimar Therapeutics, Inc. | Dir, 10%, * Dir by Deputization | 10.62M | $90.00M | — | 3 | 2022-09-16 | 2026-02-27 |
| HLSQ | Tessera Defense & Homeland Security Inc. | Dir, 10%, *Dir by Deputization | 8.94M | — | — | 2 | 2024-03-15 | 2024-07-15 |
| MIRM | Mirum Pharmaceuticals, Inc. | 10%, * Possible Member of 10% Group | 106.2K | — | $1.09M | 1 | 2021-07-02 | 2021-07-02 |
Most active insiders at LRMR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Deerfield Mgmt HIF, L.P. | Dir, 10%, * Dir by Deputization | $25.00M | — |
| 2 | Hamilton Thomas Edward | Dir | $666.9K | — |
| 3 | THOMAS FRANK E | Dir | $25.0K | — |
| 4 | SHERMAN JEFFREY W | Dir | $25.0K | — |
| 5 | Shankar Gopi | Chief Development Off | — | — |
| 6 | Clayton Russell | Chief Medical Off | — | — |
| 7 | BEN-MAIMON CAROLE | Pres, CEO, Dir | — | — |
| 8 | Celano Michael | CFO | — | — |
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-03-02 | 2026-02-27 | LRMR | Larimar Therapeutics, Inc. | Deerfield Mgmt HIF, L.P. | Dir, 10%, * Dir by Deputization | P - Purchase | $5.00 | +5.00M | 10.62M | +89% | +$25.00M |
| MI | 2025-08-04 | 2025-07-31 | LRMR | Larimar Therapeutics, Inc. | Deerfield Mgmt HIF, L.P. | Dir, 10%, * Dir by Deputization | P - Purchase | $3.20 | +9.38M | 7.32M | New | +$30.00M |
| DMI | 2024-07-17 | 2024-07-15 | HLSQ | Tessera Defense & Homeland Security Inc. | Deerfield Mgmt HIF, L.P. | Dir, *Dir by Deputization | M - OptEx | — | +11.77M | 8.94M | New | — |
| DMI | 2024-03-19 | 2024-03-15 | HLSQ | Tessera Defense & Homeland Security Inc. | Deerfield Mgmt HIF, L.P. | Dir, 10%, *Dir by Deputization | A - Grant | — | +6.11M | 3.06M | New | — |
| MI | 2022-09-20 | 2022-09-16 | LRMR | Larimar Therapeutics, Inc. | Deerfield Mgmt HIF, L.P. | Dir, 10%, * Dir by Deputization | P - Purchase | $3.15 | +11.11M | 2.78M | New | +$35.00M |
| MI | 2021-07-07 | 2021-07-02+ | MIRM | Mirum Pharmaceuticals, Inc. | Deerfield Mgmt HIF, L.P. | 10%, * Possible Member of 10% Group | S - Sale | $16.29 | -66.7K | 106.2K | -39% | -$1.09M |
Purchase Sale Sale after option exercise All abbreviations